President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower ...

Americans’ trust in the overall healthcare system is dwindling — but experts believe it can be rebuilt. Public trust in the U.S. healthcare system fell from 71.5% in 2020 to 40.1% in 2024 ...

For the past couple of years, clinicians have been singing the praises of generative AI-powered clinical documentation tools, saying that these models give them hours back into their day.

Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert.

Many drugs available and in development work by targeting proteins, an approach that comes with limitations. For one, proteins are not the root cause of disease, said Samir Ounzain, co-founder and ...

On Wednesday, Cedars-Sinai and Redesign Health launched a new innovation center that seeks to build digital health startups from the ground up. Los Angeles-based Cedars-Sinai comprises more than ...

Innovative marketing practices are the goal of every marketer; however, sometimes, it’s essential to consider not what new marketing tactic will be influential but how you can leverage existing ...

The health care industry is a critical sector that helps save people’s lives. Sometimes, medical professionals and patients have communication barriers that can hinder that process. However, the ...

Withings Health Solutions and Babyscripts announced a partnership Thursday that aims to address hypertensive disorders of pregnancy, which are among the leading causes of maternal mortality.

A rare type of ovarian cancer that grows slowly and responds poorly to chemotherapy now has its first FDA-approved treatment, a combination drug developed by Verastem Oncology to address a pathway ...

Medicaid was meant to be the solution. Then came the Affordable Care Act. But while the uninsured rate in America has reached historic lows, the financial burden on patients continues to rise.

On Friday, a San Francisco-based startup received FDA approval for the first-ever at-home cervical cancer test. The company, named Teal Health, was founded in 2020 and has raised $23 million.